5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone-Reference-Cited by-同舟云学术

5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone

Published:1996-09 Issue:5 Volume:4 Page:384-389
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

du Bois Andreas,Vach Werner,Holy Rolf,Kriesinger-Schröder Hanna

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF01788846.pdf

Reference19 articles.

1. Beck TM, Ciociola AA, Jones SE, et al (1993) Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamidebased chemotherapy. Ann Intern Med 118:407–413

2. Bonneterre J, Chevallier B, Metz R, et al (1990) A randomized doubleblind comparison of ondansetron and metoclopramid in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil and doxorubicin or epirubicin chemotherapy. J Clin Oncol 8:1063–1069

3. Bountra C, Bunce K, Dale T, et al (1993) Anti-emetic profile of a nonpeptide neurokinin NK1 receptor antagonist, CP 99,994, in ferrets. Eur J Pharmacol 249:R3-R4

4. Brasheer J, Zeitvogel C, Jackson J, et al (1989) Fluorescence polarisation immunoassay of urinary 5-hydroxy-3indoleacetic acid. Clin Chem 35:355–359

5. Buser KS, Joss RA, Piquet D, et al (1993) Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, doubleblind, placebo-controlled study. Ann Oncol 4:475–479

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment for multiple-day anthracycline-induced nausea and vomiting;Current Problems in Cancer;2019-12

2. Anti-emetic efficacy of oral granisetron in the total control of late-onset emesis induced by cyclophosphamide-containing chemotherapy;Revista de Oncología;2004-01